BRN2 is a non-canonical melanoma tumor-suppressor

Archive ouverte

Hamm, Michael | Sohier, Pierre | Petit, Valérie | Raymond, Jérémy, H | Delmas, Véronique | Le Coz, Madeleine | Gesbert, Franck | Kenny, Colin | Aktary, Zackie | Pouteaux, Marie | Rambow, Florian | Sarasin, Alain | Charoenchon, Nisamanee | Bellacosa, Alfonso | Sanchez-Del-Campo, Luis | Mosteo, Laura | Lauss, Martin | Meijer, Dies | Steingrimsson, Eirikur | Jönsson, Göran, B | Cornell, Robert, A | Davidson, Irwin | Goding, Colin, R | Larue, Lionel

Edité par CCSD ; Nature Publishing Group -

International audience. While the major drivers of melanoma initiation, including activation of NRAS/BRAF and loss of PTEN or CDKN2A, have been identified, the role of key transcription factors that impose altered transcriptional states in response to deregulated signaling is not well understood. The POU domain transcription factor BRN2 is a key regulator of melanoma invasion, yet its role in melanoma initiation remains unknown. Here, in a Braf V600E Pten F/+ context, we show that BRN2 haplo-insufficiency promotes melanoma initiation and metastasis. However, metastatic colonization is less efficient in the absence of Brn2. Mechanistically, BRN2 directly induces PTEN expression and in consequence represses PI3K signaling. Moreover, MITF, a BRN2 target, represses PTEN transcription. Collectively, our results suggest that on a PTEN heterozygous background somatic deletion of one BRN2 allele and temporal regulation of the other allele elicits melanoma initiation and progression.

Suggestions

Du même auteur

Stabilization of β-catenin promotes melanocyte specification at the expense of the Schwann cell lineage

Archive ouverte | Colombo, Sophie | CCSD

International audience. The canonical Wnt/β-catenin pathway governs a multitude of developmental processes in various cell lineages, including the melanocyte lineage. Indeed, β-catenin regulates transcription of Mit...

New Functional Signatures for Understanding Melanoma Biology from Tumor Cell Lineage-Specific Analysis.

Archive ouverte | Rambow, Florian | CCSD

International audience. Molecular signatures specific to particular tumor types are required to design treatments for resistant tumors. However, it remains unclear whether tumors and corresponding cell lines used fo...

The E-cadherin-ESR1-GRPR axis defines a sex-specific metastatic pathway in melanoma

Archive ouverte | Raymond, Jérémy | CCSD

International audience. Summary Although tremendous progress has been made in understanding the mechanisms leading to cancer, those governing metastases are still poorly understood. E-cadherin (Ecad) is a cell-cell ...

Chargement des enrichissements...